x

c

d

f

Auteur

Farini A Documents (Auteurs) Articles : Stem cell therapies to treat muscular dystrophy. Progress to date / Meregalli M ; Farini A ; Parolini D ; Maciotta S ; Torrente Y. Bio drugs, 2010. - 24, 4, p. 237-247 Articles : Combining stem cells and exon skipping strategy to treat muscular dystrophy / Meregalli M ; Farini A ; Torrente Y. Expert opinion on biological therapy, 2008. - 8, 8, p. 1051-1061 Colloques : Exon-skipping of dysferlin in CD133+ stem cells isolated from normal and patient affected with dysferlinopathies / Navarro C ; Farini A ; Meregalli M ; Belicchi M ; Parolini D ; Razini P ; Krahn M ; Wein N ; Bourg N ; Bartoli M ; Richard I ; Lévy N ; Torrente Y. 2008. - p. 189 Colloques : Perturbation of calcium handling in CD133+ stem cells isolated from dmd blood / Parolini D ; Meregalli M ; Belicchi M ; Farini A ; Razini P ; Maciotta S ; Torrente Y. 2008. - p. 142 Colloques : Muscle-specific micrornas (MIRNAS) in Duchenne muscular dystrophy (DMD) / Maciotta S ; Meregalli M ; Farini A ; Belicchi M ; Parolini D ; Bresolin N ; Torrente Y. 2008. - p. 132 Colloques : Ex vivo expansion of human circulating CD133+ progenitor cells : promising tool for cell-based therapeutic approaches in muscular dystrophy / Belicchi M ; Meregalli M ; Razini P ; Cattaneo A ; Farini A ; Iacchetti E ; Porretti L ; Milani P ; Bresolin N ; Torrente Y. 2008. - p. 101 Colloques : Abundance of circulating progenitors with myo-endothelial potential correlates with a mild phenotype in patients affected by Duchenne muscular dystrophy / Farini A ; Belicchi M ; Meregalli M ; Marchesi C ; Lopa R ; Porretti L ; Parolini D ; D'Angelo MG ; Bresolin N ; Cossu G ; Torrente Y. 2008. - p. 100 Colloques : Autologous transplantation of engineered muscle-derived CD133+ stem cells / Benchaouir R ; Meregalli M ; Farini A ; D'Antona G ; Belicchi M ; Goyenvalle A ; Parolini D ; Bresolin N ; Bottinelli R ; Garcia L ; Torrente Y. 2008. - p. 32 Articles : Correlation of circulating CD133+ progenitor subclasses with a mild phenotype in Duchenne muscular dystrophy patients / Marchesi C ; Belicchi M ; Meregalli M ; Farini A ; Cattaneo A ; Parolini D ; Gavina M ; Porretti L ; D'Angelo MG ; Bresolin N ; Cossu G ; Torrente Y. PLoS ONE, 2008. - 3, 5, e2218, p. 1-9 Articles : Réhabilitation de la dystrophine humaine dans le modèle scid/mdx après greffe de cellules souches de patients DMD corrigées par saut d'exon / Benchaouir R ; Meregalli M ; Farini A ; D'Antona G ; Belicchi M ; Goyenvalle A ; Battistelli M ; Bresolin N ; Bottinelli R ; Garcia L ; Torrente Y. MS. Médecine sciences, 2008. - 24, 1, p. 99-101 Articles : Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice / Benchaouir R ; Meregalli M ; Farini A ; D'Antona G ; Belicchi M ; Goyenvalle A ; Battistelli M ; Bresolin N ; Botinelli R ; Garcia L ; Torrente Y. Cell stem cell, 2007. - 1, p. 646-657 Articles : T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse / Farini A ; Meregalli M ; Belicchi M ; Battistelli M ; Parolini D ; D'Antona G ; Gavina M ; Ottoboni L ; Constantin G ; Bottinelli R ; Torrente Y. Journal of pathology (The), 2007. - 213, 2, p. 229-238 Articles : VCAM-1 expression on dystrophic muscle vessels has a critical role in the recruitment of human blood-derived CD133+ stem cells after intra-arterial transplantation / Gavina M ; Belicchi M ; Rossi B ; Ottoboni L ; Colombo F ; Meregalli M ; Battistelli M ; Forzenigo L ; Biondetti P ; Pisati F ; Parolini D ; Farini A ; Issekutz AC ; Bresolin N ; Rustichelli F ; Constantin G ; Torrente Y. Blood, 2006. - 108, 8, p. 2857-2866

Envoyer par email Imprimer Commander le document